Transdermal Skin Patch Market Report: Trends, Forecast and Competitive Analysis to 2030
Get it in 2 to 4 weeks by ordering today
Transdermal Skin Patch Trends and Forecast
The future of the global transdermal skin patch market looks promising with opportunities in the pain relief, smoking reduction and cessation aid, overactive bladder, and hormonal therapy markets. The global transdermal skin patch market is expected to reach an estimated $9.7 billion by 2030 with a CAGR of 4.7% from 2024 to 2030. The major drivers for this market are growing benefits over oral and ingested drugs, convenience of use, and extended duration of the drug's action, as well as, increasing funding and investments for drug development.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Transdermal Skin Patch by Segment
The study includes a forecast for the global transdermal skin patch by type, application, and region.
Transdermal Skin Patch Market by Type [Shipment Analysis by Value from 2018 to 2030]:
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies transdermal skin patch companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the transdermal skin patch companies profiled in this report include-
Lucintel forecasts that single-layer drug-in-adhesive is expected to witness the highest growth over the forecast period.
North America will remain the largest region over the forecast period due to the presence of key stakeholders and a well-established health care system in the region.
Features of the Global Transdermal Skin Patch Market
Market Size Estimates: Transdermal skin patch market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Transdermal skin patch market size by type, application, and region in terms of value ($B).
Regional Analysis: Transdermal skin patch market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the transdermal skin patch market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the transdermal skin patch market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the transdermal skin patch market size?
Answer: The global transdermal skin patch market is expected to reach an estimated $9.7 billion by 2030.
Q2. What is the growth forecast for transdermal skin patch market?
Answer: The global transdermal skin patch market is expected to grow with a CAGR of 4.7% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the transdermal skin patch market?
Answer: The major drivers for this market are growing benefits over oral and ingested drugs, convenience of use, and extended duration of the drug's action, as well as, increasing funding and investments for drug development.
Q4. What are the major segments for transdermal skin patch market?
Answer: The future of the global transdermal skin patch market looks promising with opportunities in the pain relief, smoking reduction and cessation aid, overactive bladder, and hormonal therapy markets.
Q5. Who are the key transdermal skin patch market companies?
Answer: Some of the key transdermal skin patch companies are as follows:
Answer: Lucintel forecasts that single-layer drug-in-adhesive is expected to witness the highest growth over the forecast period.
Q7. In transdermal skin patch market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to the presence of key stakeholders and a well-established health care system in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the transdermal skin patch market by type (single-layer drug-in-adhesive, multi-layer drug-in-adhesive, matrix, and others), application (pain relief, smoking reduction and cessation aid, overactive bladder, hormonal therapy, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Transdermal Skin Patch Market, Transdermal Skin Patch Market Size, Transdermal Skin Patch Market Growth, Transdermal Skin Patch Market Analysis, Transdermal Skin Patch Market Report, Transdermal Skin Patch Market Share, Transdermal Skin Patch Market Trends, Transdermal Skin Patch Market Forecast, Transdermal Skin Patch Companies, write Lucintel analyst at email: [email protected]. We will be glad to get back to you soon.
Transdermal Skin Patch Trends and Forecast
The future of the global transdermal skin patch market looks promising with opportunities in the pain relief, smoking reduction and cessation aid, overactive bladder, and hormonal therapy markets. The global transdermal skin patch market is expected to reach an estimated $9.7 billion by 2030 with a CAGR of 4.7% from 2024 to 2030. The major drivers for this market are growing benefits over oral and ingested drugs, convenience of use, and extended duration of the drug's action, as well as, increasing funding and investments for drug development.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Transdermal Skin Patch by Segment
The study includes a forecast for the global transdermal skin patch by type, application, and region.
Transdermal Skin Patch Market by Type [Shipment Analysis by Value from 2018 to 2030]:
- Single-Layer Drug-In-Adhesive
- Multi-Layer Drug-In-Adhesive
- Matrix
- Others
- Pain Relief
- Smoking Reduction and Cessation Aid
- Overactive Bladder
- Hormonal Therapy
- Others
- North America
- Europe
- Asia Pacific
- The Rest of the World
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies transdermal skin patch companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the transdermal skin patch companies profiled in this report include-
- Teva Pharmaceutical Industries
- Novartis
- Teikoku Pharma
- Viatris
- Johnson & Johnson
- Luye Pharma Group
- Purdue Pharma Manufacturing
Lucintel forecasts that single-layer drug-in-adhesive is expected to witness the highest growth over the forecast period.
North America will remain the largest region over the forecast period due to the presence of key stakeholders and a well-established health care system in the region.
Features of the Global Transdermal Skin Patch Market
Market Size Estimates: Transdermal skin patch market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Transdermal skin patch market size by type, application, and region in terms of value ($B).
Regional Analysis: Transdermal skin patch market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the transdermal skin patch market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the transdermal skin patch market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the transdermal skin patch market size?
Answer: The global transdermal skin patch market is expected to reach an estimated $9.7 billion by 2030.
Q2. What is the growth forecast for transdermal skin patch market?
Answer: The global transdermal skin patch market is expected to grow with a CAGR of 4.7% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the transdermal skin patch market?
Answer: The major drivers for this market are growing benefits over oral and ingested drugs, convenience of use, and extended duration of the drug's action, as well as, increasing funding and investments for drug development.
Q4. What are the major segments for transdermal skin patch market?
Answer: The future of the global transdermal skin patch market looks promising with opportunities in the pain relief, smoking reduction and cessation aid, overactive bladder, and hormonal therapy markets.
Q5. Who are the key transdermal skin patch market companies?
Answer: Some of the key transdermal skin patch companies are as follows:
- Teva Pharmaceutical Industries
- Novartis
- Teikoku Pharma
- Viatris
- Johnson & Johnson
- Luye Pharma Group
- Purdue Pharma Manufacturing
Answer: Lucintel forecasts that single-layer drug-in-adhesive is expected to witness the highest growth over the forecast period.
Q7. In transdermal skin patch market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to the presence of key stakeholders and a well-established health care system in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the transdermal skin patch market by type (single-layer drug-in-adhesive, multi-layer drug-in-adhesive, matrix, and others), application (pain relief, smoking reduction and cessation aid, overactive bladder, hormonal therapy, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Transdermal Skin Patch Market, Transdermal Skin Patch Market Size, Transdermal Skin Patch Market Growth, Transdermal Skin Patch Market Analysis, Transdermal Skin Patch Market Report, Transdermal Skin Patch Market Share, Transdermal Skin Patch Market Trends, Transdermal Skin Patch Market Forecast, Transdermal Skin Patch Companies, write Lucintel analyst at email: [email protected]. We will be glad to get back to you soon.
1. EXECUTIVE SUMMARY
2. GLOBAL TRANSDERMAL SKIN PATCH MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Transdermal Skin Patch Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Transdermal Skin Patch Market by Type
3.3.1: Single-layer Drug-in-Adhesive
3.3.2: Multi-layer Drug-in-Adhesive
3.3.3: Matrix
3.3.4: Others
3.4: Global Transdermal Skin Patch Market by Application
3.4.1: Pain Relief
3.4.2: Smoking Reduction and Cessation Aid
3.4.3: Overactive Bladder
3.4.4: Hormonal Therapy
3.4.5: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Transdermal Skin Patch Market by Region
4.2: North American Transdermal Skin Patch Market
4.2.1: North American Transdermal Skin Patch Market by Type: Single-layer Drug-in-Adhesive, Multi-layer Drug-in-Adhesive, Matrix, and Others
4.2.2: North American Transdermal Skin Patch Market by Application: Pain Relief, Smoking Reduction and Cessation Aid, Overactive Bladder, Hormonal Therapy, and Others
4.3: European Transdermal Skin Patch Market
4.3.1: European Transdermal Skin Patch Market by Type: Single-layer Drug-in-Adhesive, Multi-layer Drug-in-Adhesive, Matrix, and Others
4.3.2: European Transdermal Skin Patch Market by Application: Pain Relief, Smoking Reduction and Cessation Aid, Overactive Bladder, Hormonal Therapy, and Others
4.4: APAC Transdermal Skin Patch Market
4.4.1: APAC Transdermal Skin Patch Market by Type: Single-layer Drug-in-Adhesive, Multi-layer Drug-in-Adhesive, Matrix, and Others
4.4.2: APAC Transdermal Skin Patch Market by Application: Pain Relief, Smoking Reduction and Cessation Aid, Overactive Bladder, Hormonal Therapy, and Others
4.5: ROW Transdermal Skin Patch Market
4.5.1: ROW Transdermal Skin Patch Market by Type: Single-layer Drug-in-Adhesive, Multi-layer Drug-in-Adhesive, Matrix, and Others
4.5.2: ROW Transdermal Skin Patch Market by Application: Pain Relief, Smoking Reduction and Cessation Aid, Overactive Bladder, Hormonal Therapy, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Transdermal Skin Patch Market by Type
6.1.2: Growth Opportunities for the Global Transdermal Skin Patch Market by Application
6.1.3: Growth Opportunities for the Global Transdermal Skin Patch Market by Region
6.2: Emerging Trends in the Global Transdermal Skin Patch Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Transdermal Skin Patch Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Transdermal Skin Patch Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Teva Pharmaceutical Industries
7.2: Novartis
7.3: Teikoku Pharma
7.4: Viatris
7.5: Johnson & Johnson
7.6: Luye Pharma Group
7.7: Purdue Pharma Manufacturing
2. GLOBAL TRANSDERMAL SKIN PATCH MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Transdermal Skin Patch Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Transdermal Skin Patch Market by Type
3.3.1: Single-layer Drug-in-Adhesive
3.3.2: Multi-layer Drug-in-Adhesive
3.3.3: Matrix
3.3.4: Others
3.4: Global Transdermal Skin Patch Market by Application
3.4.1: Pain Relief
3.4.2: Smoking Reduction and Cessation Aid
3.4.3: Overactive Bladder
3.4.4: Hormonal Therapy
3.4.5: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Transdermal Skin Patch Market by Region
4.2: North American Transdermal Skin Patch Market
4.2.1: North American Transdermal Skin Patch Market by Type: Single-layer Drug-in-Adhesive, Multi-layer Drug-in-Adhesive, Matrix, and Others
4.2.2: North American Transdermal Skin Patch Market by Application: Pain Relief, Smoking Reduction and Cessation Aid, Overactive Bladder, Hormonal Therapy, and Others
4.3: European Transdermal Skin Patch Market
4.3.1: European Transdermal Skin Patch Market by Type: Single-layer Drug-in-Adhesive, Multi-layer Drug-in-Adhesive, Matrix, and Others
4.3.2: European Transdermal Skin Patch Market by Application: Pain Relief, Smoking Reduction and Cessation Aid, Overactive Bladder, Hormonal Therapy, and Others
4.4: APAC Transdermal Skin Patch Market
4.4.1: APAC Transdermal Skin Patch Market by Type: Single-layer Drug-in-Adhesive, Multi-layer Drug-in-Adhesive, Matrix, and Others
4.4.2: APAC Transdermal Skin Patch Market by Application: Pain Relief, Smoking Reduction and Cessation Aid, Overactive Bladder, Hormonal Therapy, and Others
4.5: ROW Transdermal Skin Patch Market
4.5.1: ROW Transdermal Skin Patch Market by Type: Single-layer Drug-in-Adhesive, Multi-layer Drug-in-Adhesive, Matrix, and Others
4.5.2: ROW Transdermal Skin Patch Market by Application: Pain Relief, Smoking Reduction and Cessation Aid, Overactive Bladder, Hormonal Therapy, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Transdermal Skin Patch Market by Type
6.1.2: Growth Opportunities for the Global Transdermal Skin Patch Market by Application
6.1.3: Growth Opportunities for the Global Transdermal Skin Patch Market by Region
6.2: Emerging Trends in the Global Transdermal Skin Patch Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Transdermal Skin Patch Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Transdermal Skin Patch Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Teva Pharmaceutical Industries
7.2: Novartis
7.3: Teikoku Pharma
7.4: Viatris
7.5: Johnson & Johnson
7.6: Luye Pharma Group
7.7: Purdue Pharma Manufacturing
